Farther Finance Advisors’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$784 Sell
30
-27
-47% -$686 ﹤0.01% 5429
2026
Q1
$1.48K Sell
57
-222
-80% -$5.25K ﹤0.01% 4999
2025
Q4
$7.35K Buy
279
+217
+350% +$4.73K ﹤0.01% 4106
2025
Q3
$1.06K Buy
62
+37
+148% +$530 ﹤0.01% 4349
2025
Q2
$314 Sell
25
-114
-82% -$1.36K ﹤0.01% 4130
2025
Q1
$1.61K Sell
139
-11
-7% -$150 ﹤0.01% 3462
2024
Q4
$2.2K Hold
150
﹤0.01% 2963
2024
Q3
$1.88K Hold
150
﹤0.01% 3017
2024
Q2
$1.29K Buy
150
+125
+500% +$1.11K ﹤0.01% 2972
2024
Q1
$247 Hold
25
﹤0.01% 3221
2023
Q4
$260 Buy
+25
New +$199 ﹤0.01% 3166

Other funds holding ZYME

Farther Finance Advisors's ZYME Position: Q2 2026 in Review

Farther Finance Advisors reduced its Zymeworks (ZYME) stake by 47% in Q2 2026, selling an estimated $686 and leaving 30 shares worth $784. The position accounts for ﹤0.01% of the portfolio, ranked #5429.

Farther Finance Advisors first reported a position in ZYME in Q4 2023 and has held it in 11 quarters since. The position peaked at $7.35K in Q4 2025. 8 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Farther Finance Advisors held 30 shares of Zymeworks worth $784 as of Q2 2026.
  • Farther Finance Advisors sold 27 Zymeworks shares in Q2 2026, an estimated $686.
  • Zymeworks made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5429 holding.
  • Farther Finance Advisors first reported a position in Zymeworks in Q4 2023 and has held it in 11 quarters since.
  • Farther Finance Advisors's Zymeworks position peaked at $7.35K in Q4 2025.
  • 8 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.